Jul. 27 at 11:54 PM
Universal Health Services reported mixed Q2 2026 results, with revenue slightly beating expectations but earnings missing by a wide margin. EPS came in at
$5.35, well below the
$5.95 consensus estimate, while revenue of
$4.64 billion topped forecasts of
$4.58 billion.
Investor sentiment was further hurt by a cut to full-year guidance. UHS lowered its 2026 EPS outlook to
$22.28–
$23.65, with the midpoint below the analyst consensus of
$23.39, while revenue guidance of
$18.5 billion–
$18.76 billion was roughly in line with expectations. The weaker outlook reinforced concerns about staffing shortages, payer mix deterioration, and Medicaid reimbursement risks that had already weighed on the stock.
The after-hours decline reflected the combination of an earnings miss, reduced profit guidance, and ongoing sector headwinds, increasing concerns that margin recovery may take longer than investors had anticipated.
$UHS